Le Glypican-3 (GPC3) est surexprimé dans 72% des carcinomes hépatocellulaire (CHC). C’est un co-récepteur membranaire du récepteur WNT, qui appartient à la famille des protéoglycanes à sulfates d'héparane. L'objectif général de ma thèse vise à étudier les mécanismes de régulation post-transcriptionnelle de l’expression du GPC3 dans le CHC. Pour cela, j’ai développé un test fonctionnel qui m’a permis de cribler une bibliothèque de 876 microARNs humains. Ceci a conduit à l’identification de 5 microARNs régulateurs de l’expression de l’ARNm codant pour le GPC3 via sa région 3’ non traduite (NT). Mon travail de thèse porte plus particulièrement sur le miR-1271 et le miR-1291 car ils sont dérégulés dans le CHC et sont respectivement inhibiteur et inducteur de l’expression du GPC3. Dans un premier projet, j’ai démontré que le miR-1271 cible directement la région 3’NT du GPC3 et diminue la stabilité de son ARNm. Ce microARN est sous-exprimé dans le CHC et son expression corrèle négativement avec celle de l'ARNm du GPC3 dans les CHC associés à une infection par le virus de l’hépatite B. Dans un deuxième projet, j’ai démontré que le miR-1291 régule positivement l’expression du GPC3 en inhibant un facteur intermédiaire. Une analyse in silico a permis d’identifier IRE1α comme candidat. IRE1α est une protéine transmembranaire du réticulum endoplasmique (RE) qui participe à « l’Unfolded Protein Response », une réponse adaptative activée lors de l’accumulation de protéines mal conformées dans le RE. J’ai démontré qu’IRE1α clive l’ARNm codant pour le GPC3 grâce à son activité endoribonucléase. D’autre part, le miR-1291 cible directement l’ARNm codant pour IRE1α dans sa région 5’NT ce qui inhibe son expression et induit une surexpression du GPC3. Le miR-1291 est surexprimé dans le CHC et son expression corrèle positivement avec celle de l’ARNm du GPC3. En conclusion, mon travail de thèse m’a permis de mettre en évidence et de caractériser deux nouveaux microARNs (miR-1271 et miR-1291) contrôlant l’expression du GPC3 par des mécanismes directs ou indirects. La pertinence physiopathologique de ces régulations dans le CHC est en accord avec les niveaux d’expression respectifs de ces microARNs, qui pourraient contribuer à la surexpression du GPC3 dans ces tumeurs. / Glypican-3 (GPC3) is overexpressed in 72% of hepatocellular carcinoma (HCC). It is a co-receptor for WNT receptor and belongs to the heparan sulfate proteoglycans family. The general objective of my PhD thesis was to study the mechanisms by which GPC3 is post-transcriptionnally regulated in HCC. To this end, I developed a functional test that allowed me to screen a library of 876 human microRNAs. This led me to identify 5 microRNAs that regulate the expression of GPC3 mRNA through its 3’Untranslated Region (UTR). The work presented in this thesis particulary focuses on miR-1271 and miR-1291 as both microRNAs present a deregulated expression in HCC and are respectively inhibitor and activator of GPC3 mRNA expression. In a first project, I demonstrated that miR-1271 directly binds to GPC3 mRNA 3’UTR and affects its stability. This microRNA is underexpressed in HCC and its expression negatively correlates with that of GPC3 mRNA in a subgroup of HCC corresponding to those associated with hepatitis B virus infection. In a second project, I demonstrated that miR-1291 postively regulates the expression of GPC3 mRNA by targeting an intermediate factor. An in silico analysis led to the identification of the Inositol Requiring Enzyme 1 alpha (IRE1α) as a potential candidate. IRE1α is an endoplasmic reticulum (ER) resident type I transmembrane protein and contributes to the signaling of the Unfolded Protein Response (UPR). The UPR is an adaptive response activated upon accumulation of improperly folded proteins in the ER. I showed that IRE1α cleaves GPC3 mRNA through its endoribonuclease activity. Moreover I demonstrated that miR-1291 directly targets IRE1α mRNA through its 5’UTR, thereby decreasing its expression and contributing to GPC3 mRNA overexpression. MiR-1291 is overexpressed in HCC and its expression positively correlates with that of GPC3 mRNA. In summary, the work carried out during my PhD allowed the identification and the characterization of two new microRNAs (miR-1271 and miR-1291) that control the expression of GPC3 mRNA through direct or indirect mechanisms. The pathophysiological relevance of these regulatory mechanisms is in agreement with the respective expression levels of these microRNAs in HCC, which could therefore contribute to the overexpression of GPC3 in those tumors.

Diabetes é uma doença metabólica caracterizada por hiperglicemia associada a prejuízos na captação e utilização de glicose, em que reduções na expressão da proteína GLUT4 (codificada pelo gene SLC2A4), bem como das enzimas Hexokinase-2 e Glycogen synthase (codificadas pelos genes HK2 e GYS1), desempenham papel importante. Recentemente, um novo elemento vem sendo relacionado à etiopatogenia e à fisiopatologia do diabetes, os microRNAs (miRNAs), que são pequenos RNAs envolvidos na regulação da expressão gênica, geralmente afetando a degradação de mRNAs. Entretanto, a participação de miRNAs envolvidos na redução da expressão de mRNAs relacionados a proteínas envolvidas na captação e utilização de glicose, sobretudo em músculo esquelético, permanece desconhecida. O objetivo desse estudo foi investigar a expressão de miRNAs potencialmente reguladores da expressão de Slc2a4/GLUT4, Hk2/HK2 e Gys1/GYS1 em músculo esquelético de ratos diabéticos. Utilizamos ratos Wistar machos que foram tornados diabéticos pela administração de estreptozotocina. Após 13 dias, 3 grupos foram formados: não-diabético (ND) e diabético tratado com placebo (DP) ou insulina (DI). O tratamento foi conduzido por 7 dias, totalizando 21 dias de diabetes. Variáveis metabólicas foram avaliadas e os músculos sóleos foram removidos para avaliar a expressão de mRNAs, miRNAs e proteínas. Uma abrangente análise in silico foi conduzida para determinar miRNAs candidatos a regularem a expressão de Slc2a4, Hk2 e Gys1. Os animais diabéticos apresentaram perda de peso, poliúria, glicosúria, hiperglicemia e aumento de frutosamina plasmática; a insulinoterapia melhorou estas variáveis. O diabetes reduziu a expressão dos mRNAs Slc2a4 (~55%), Hk2 (~47%) e Gys1 (~45%), e das proteínas GLUT4 (~77%), HK2(~52%) e GYS1 (~49%); a insulinoterapia restaurou essas variáveis. A expressão de 20 miRNAs foi avaliada neste estudo; 8 foram modulados pelo diabetes, sendo três supra-regulados, miR-1 (~28%), miR-29b (~118%) e miR-29c (~51%); e cinco infra-regulados, miR-93 (~39%), miR-199a (~30%), miR-345-3p (~23%), miR-532-3p (~26%) e miR-150 (~32%). Exceto pelo miR-1 e miR-150, a insulinoterapia reverteu as demais alterações. Além disso, miR-29b e miR-29c correlacionaram-se negativamente com GLUT4 e HK2, e positivamente com glicemia, glicosúria e frutosamina, sugerindo uma possível relação causal; enquanto que miR-199a e miR-532-3p correlacionaram-se positivamente com GLUT4 e HK2, e também com as variáveis metabólicas, sugerindo uma regulação indireta sobre os mRNAs dessas proteínas. No último caso, demonstrou-se que o miR-199a tem como alvo o NFKB1, um repressor do gene Slc2a4, o qual diminuiu no diabetes, explicando, pelo menos parcialmente, o efeito indireto sobre o GLUT4. Em suma, o diabetes aumenta a expressão de miR-29b e miR-29c, e reduz a expressão de miR-199a e miR-532-3p; o primeiro efeito, potencialmente age diretamente na tradução do mRNA Slc2a4 e Hk2, e o segundo, potencialmente age indiretamente, via NFKB, na transcrição dos genes. Como consequência, as proteínas GLUT4 e HK2 diminuem, o que reduziria a utilização de glicose pelo músculo, contribuindo para a hiperglicemia do diabetes. / Diabetes is a metabolic disease characterized by hyperglycemia associated with impaired glucose metabolism and uptake, in which reductions of GLUT4, hexokinase 2 (HK2) and glycogen synthase 1 (GYS1) proteins, encoded respectively by SLC2A4, HK2 and GYS1 genes, play an important role. Recently, a new element have been related to etiopathogeny and pathophysiology of diabetes, the microRNAs (miRNAs), which are small RNAs involved in the regulation of gene expression, usually by affecting the degradation of mRNAs. However, the participation of miRNAs diabetes-induced reduction of expression of genes related to glucose uptake and metabolism in skeletal muscle remains unknown. Thus, the objective of this study was to investigate the expression of miRNAs potentially regulators of the Slc2a4/GLUT4, Hk2/HK2 and Gys1/GYS1 in skeletal muscle of diabetic rats. Male Wistar rats were rendered diabetic by receiving streptozotocin. After 13 days, 3 groups were formed: non-diabetic (ND), and diabetic treated with placebo (DP) or insulin (DI) (NPH insulin, 6U/day). Treatment was conducted for 7 days, totalizing 21 days of diabetes. At the end of the experimental period, metabolic variables were evaluated and the soleus muscle was removed for evaluation of mRNA, miRNA and protein expression. A broad in silico analysis was performed to determine candidate miRNAs as potential regulators of Slc2a4, Hk2 and Gys1. Diabetic rats shown weight loss, polyuria, glycosuria, hyperglycemia and increased plasma fructosamine; insulin treatment improved these variables. Diabetes reduced Slc2a4 (~55%), Hk2 (~47%) and Gys1 (~45%) mRNAs, as well as GLUT4 (77%), HK2 (52%) and GYS1 (49%) proteins; insulin treatment restored these variables. Twenty miRNAs were assessed in this study. Eight miRNAs were modulated by diabetes in skeletal muscle; three were upregulated: miR-1 (28%), miR-29b (118%) and miR-29c (51%), whereas five were downregulated: miR-93 (39%), miR-150 (32%), miR-199a (30%), miR-345-3p (23%) and miR-532-3p (26%). Except for miR-1 and miR-150, all regulations were reverted by insulin treatment. Besides, miR-29b and miR-29c were negatively correlated with GLUT4 and HK2 proteins, and positively with glucose, glycosuria and plasma fructosamine suggesting a direct causal relationship; while miR-199a and miR-532-3p were positively correlated with GLUT4 and HK2 proteins, and also with the metabolic variables, suggesting an indirect causal relationship. In the last case, it was demonstrated that miR-199a has the Slc2a4 repressor Nfkb1 as target, which was reduced in muscle from diabetic rats, explaining, at least partially, the indirect effect upon GLUT4. In conclusion, diabetes increase the expression of miR-29b and miR-29c, and reduce the expression of miR-199a e miR-532-3p; the first effect, potentially acts directly in the translation of Slc2a4 and Hk2 mRNAs, and the second one, potentially acts indirectly, via NFKB, in the transcription of these genes. As a result, the expression of GLUT4 and HK2 decreases, which would reduce the muscle glucose uptake and metabolization, contributing to the hyperglycemia of the diabetes.

No description available.

Epithelial ovarian cancer (EOC) is a leading cause of morbidity and mortality among women in the United States, and the etiology is incompletely understood. Common, low penetrant genetic variants such as single nucleotide polymorphisms (SNPs) likely contribute to a significant proportion of EOC. We examined whether SNPs in two understudied yet biologically important types of genes, mitochondrial-related and miRNA-related genes, may contribute to EOC susceptibility using data from a large, homogeneous study population of 1,815 EOC cases and 1,900 controls (frequency-matched on age-group and race/ethnicity) genotyped through stage 1 of an ongoing genome-wide association study. Inter-individual variation in genes involved in mitochondrial biogenesis was strongly associated with EOC risk (empirical P=0.050), especially for genes NRF1, PPARGC1A, MTERF, ESRRA, and CAMK2D. SNPs in several genes involved in the biogenesis of miRNAs (LIN28, LIN28B, AGO2, DICER, and DROSHA) also demonstrated associations with EOC risk; a joint meta-analysis and in vitro investigations reinforced evidence for a protective role of LIN28B rs12194974 (combined OR= 0.90, 95% CI: 0.82-0.98), a G>A SNP predicted to reside in a transcription factor binding site in the highly conserved LIN28B promoter. Our findings provide valuable insight into the pathogenesis of EOC, and support the consideration of variants in these genes as candidates when building risk prediction models. Most importantly, this work has provided a strong foundation for further lines of research that may aid in reducing the burden of this disease.

Most free-living bacteria will encounter different environments and it is therefore critical to be able to rapidly adjust to new growth conditions in order to be competitively successful. Responding to changes requires efficient gene regulation in terms of transcription, RNA stability, translation and post-translational modifications. Studies of an extremely slow-growing mutant of Salmonella enterica, with a Glu125Arg mutant version of EF-Tu, revealed it to be trapped in a stringent response. The perceived starvation was demonstrated to be the result of increased mRNA cleavage of aminoacyl-tRNA synthetase genes leading to lower prolyl-tRNA levels. The mutant EF-Tu caused an uncoupling of transcription and translation, leading to increased turnover of mRNA, which trapped the mutant in a futile stringent response. To examine the essentiality of RNase E, we selected and mapped three classes of extragenic suppressors of a ts RNase E phenotype. The ts RNase E mutants were defective in the degradation of mRNA and in the processing of tRNA and rRNA. Only the degradation of mRNA was suppressed by the compensatory mutations. We therefore suggest that degradation of at least a subset of cellular mRNAs is an essential function of RNase E. Bioinformatically, we discovered that the mRNA of tufB, one of the two genes encoding EF-Tu, could form a stable structure masking the ribosomal binding site. This, together with previous studies that suggested that the level of EF-Tu protein could affect the expression of tufB, led us to propose three models for how this could occur. The stability of the tufB RNA structure could be affected by the elongation rate of tufB-translating ribosomes, possibly influenced by the presence of rare codons early in the in tufB mRNA. Using proteomic and genetic assays we concluded that two previously isolated RNAP mutants, each with a growth advantage when present as subpopulations on aging wild-type colonies, were dependent on the utilization of acetate for this phenotype. Increased growth of a subpopulation of wild-type cells on a colony unable to re-assimilate acetate demonstrated that in aging colonies, acetate is available in levels sufficient to sustain the growth of at least a small subpopulation of bacteria.

Submitted by Karin Goebel (karing@fiocruz.br) on 2014-11-25T18:05:56Z No. of bitstreams: 1 Dissertação Bruna Hilzendeger Marcon.pdf: 6455497 bytes, checksum: 8ea632ce91cdf16edd8b86a624972dba (MD5) / Approved for entry into archive by Karin Goebel (karing@fiocruz.br) on 2014-11-25T18:06:29Z (GMT) No. of bitstreams: 1 Dissertação Bruna Hilzendeger Marcon.pdf: 6455497 bytes, checksum: 8ea632ce91cdf16edd8b86a624972dba (MD5) / Made available in DSpace on 2014-11-25T18:06:29Z (GMT). No. of bitstreams: 1 Dissertação Bruna Hilzendeger Marcon.pdf: 6455497 bytes, checksum: 8ea632ce91cdf16edd8b86a624972dba (MD5) Previous issue date: 2014 / Fundação Oswaldo Cruz. Instituto Carlos Chagas. Curitiba, PR, Brasil / As células-tronco (CTs) caracterizam-se por possuírem a capacidade de se autorrenovar e de dar origem a um ou mais tipos celulares diferenciados. Nos últimos anos, diversos trabalhos mostraram a existência de CTs em tecidos adultos, tornando-as uma alternativa interessante para uso em terapias celulares. Contudo, para melhor utilizar as CTs, é preciso primeiramente compreender como ocorre a diferenciação em um tipo celular específico e, principalmente, como é regulada a expressão gênica durante este processo. Em 2009, Ingolia e colaboradores apresentaram uma nova técnica conhecida como ribosome profiling, a qual consiste no isolamento e sequenciamento em larga escala dos fragmentos de RNA associados e protegidos pelos ribossomos, os quais têm um tamanho aproximado de 30 nucleotídeos (conhecido com footprint ribossomal). Ao mapear as sequências obtidas, é possível obter informações não apenas sobre quais sequências estão sendo traduzidas, mas também sobre a cinética da tradução e sua extensiva rede de regulação. Assim, o objetivo deste trabalho foi aplicar a técnica de ribosome profiling ao estudo do processo de diferenciação de CTs adultas. Como modelo de estudo, foram utilizadas CTs obtidas de tecido adiposo antes (t=0) e após a indução para diferenciação adipogênica por 3 dias (t=72h). O primeiro passo do trabalho foi a adaptação do protocolo de ribosome profiling para o estudo de CTs adultas, o qual consiste na lise celular, digestão do lisado com uma RNA nuclease (a qual irá degradar o RNA exposto, preservando os fragmentos protegidos pelo ribossomo), ultracentifrugação do homogenato sobre colchão de sacarose 1 M para sedimentação dos ribossomos, extração de RNA e isolamento dos fragmentos de 30 nucleotídeos. Também foi feita extração do RNA poliA. As amostras foram sequenciadas (SOLiD™) e os dados obtidos foram triados e mapeados contra um banco de dados de RNAm, utilizando-se a ferramenta CLC Genomics Workbench. Foram identificados mais de 8.000 transcritos para as amostras de ribosome profiling e mais de 17.000 para as de poliA. Ao calcular o fold change entre as condições t=0 e t=72h, foi possível verificar que mais de 50% dos genes foram detectados como diferencialmente expressos apenas por ribosome profiling. Observou-se que genes relacionados com vias de diferenciação adipogênica e de metabolismo de lipídeos encontravam-se regulados positivamente em ambas as amostras de RNA. Por outro lado, observou-se que vias de regulação do citoesqueleto de actina e de adesão focal estavam reguladas negativamente apenas nas amostras de ribosome profiling. Isso é interessante, uma vez que a inibição destas vias já foi descrita como importante para o processo de adipogênese. Além disso, foi observada uma forte redução na eficiência de tradução de genes relacionados com a tradução após 72 horas de indução para diferenciação. Os resultados obtidos no presente trabalho reforçam as evidências de que os mecanismos de regulação pós-transcricionais e traducionais têm um papel muito importante na regulação da diferenciação celular de CTs, sendo que a técnica de ribosome profiling permitiu obter informações mais detalhadas de como este processo pode estar acontecendo. / Stem cells (SC) are characterized by their capacity of both self-renewing and giving rise to new differentiated cells. SC are found in adult tissues, which are considered a putative source for cell therapy. However, little is known about the mechanisms involved in the trigger of SCs differentiation into a specific cell type. Understanding adult SCs differentiation process is a fundamental step to better use and to take advantage of their potential. In 2009, Ingolia and collaborators presented a new methodology of transcriptome analysis named ribosome profiling, which consists on the isolation and deep-sequencing of the mRNA fragments enclosed by ribosomes. When lysed cells are submitted to nuclease digestion, unprotected mRNA is degraded, while fragments within ribosomes are preserved and have a known footprint of 30 nucleotides. Sequencing these ribosome-protected fragments results in a high-precision measurement of in vivo translation, providing precise information about translation kinetics and its extensive regulation. The objective of this work was to apply the ribosome profiling methodology to the study of adipogenic differentiation in adult SCs. SCs were isolated from human adipose tissue from three donors and were cultured in a control medium (t=0) and induced to adipogenic differentiation for 72 hours (t=72h). The first step was to adapt and optimize the ribosome profiling protocol to the SC model, which consists in cell lysis, cell lysate digestion by nuclease (to degrade unprotected RNA, preserving ribosome-protected fragments), ultracentrifugation over a 1M sucrose cushion to pellet ribosomes, RNA extraction and 30 nucleotides fragments isolation. poliA RNA was also isolated. Samples were submitted to deep-sequencing (SOLiD™) and the reads obtained were trimmed and mapped onto the reference mRNA database using the CLC Genomics Workbench. Over 8000 transcripts were identified in ribosome profiling samples and over 17000 in poliA samples. Fold change analysis between t=0 and t=72h of both RNA samples showed that differential expression of more than 50% of the genes was identified only by ribosome profiling. Pathways related to adipogenesis and lipid metabolism were upregulated in both RNA samples. However, regulation of the actin cytoskeleton and focal adhesion proteins were downregulated only in ribosome profiling samples. Interestingly, downregulation of these pathways was already described as an important phenomenon to cell adipogenesis. Besides, we observed a strong reduction of translational efficiency of genes involved in translation at t=72h. Our results reinforce previous data, suggesting that posttranscriptional and translational regulation play a fundamental role in the regulation of SC differentiation process and that ribosome profiling is an important tool to better understand this process.

L’inhibition, par p16INK4a, de la progression du cycle cellulaire est considérée comme liée à un arrêt de la progression en phase G1 du à l’inhibition de l’activité de CDK4/6. Nous montrons que l’expression ectopique de p16INK4a dans trois lignées cellulaires malignes, p16-/- et pRb+/+, issues de tissus différents, provoque un allongement de la durée de la phase S et du cycle cellulaire total. L’ensemble de nos travaux sur p16INK4a sauvage et son mutant p16G101W indique que p16INK4a induit un allongement de la phase S i) indépendamment de l’origine tissulaire des cellules analysées et ii) en partie lié aux conséquences de l’inhibition de l’activité de CDK4/6 et peut-être des MAP-kinases. Dans sa localisation nucléaire, p16INK4a interviendrait dans la régulation du cycle cellulaire indépendamment de sa liaison à CDK4. L’expression de CDK1 est inhibée par p16INK4a dans les trois lignées analysées. Dans les cellules MCF7 et U87, cette inhibition est post-transcriptionnelle, médiée par la région 3’non traduite de l’ARNm de CDK1, et est associée à une modification de l’équilibre d’expression, tissu-spécifique, des microARN régulant potentiellement CDK1. Nous démontrons que CDK1 est une cible de miR- 410 et miR-650 induits par p16INK4a et le rôle de l’inhibition de la voie pRb/E2F par p16INK4a dans l’induction de miR-410. Ainsi, p16INK4a régule l’expression des gènes à différents niveaux en modifiant l’équilibre fonctionnel des facteurs de transcription et, en conséquence, des miARN. / The inhibition of cell cycle progression by p16INK4a, have been considered to result from arrest in G1 phase due to inhibition of CDK4/6 activity. We show that ectopic expression of p16INK4a in three human malignant cell lines, p16-/- and pRb +/ +, derived from different tissues, led to an increase in the length of S phase and of the entire cell cycle. Our studies using wild-type p16INK4a and p16G101W mutant indicated that p16INK4a induces a lengthening of S phase i) independently of tissue origins and ii) partly linked to the inhibition of CDK4/6 activity and possibly MAP-kinases. In the nucleus, p16INK4a may intervene in regulating the cell cycle independently of binding to CDK4. The expression of CDK1 is inhibited by p16INK4a in three cell lines analyzed. In MCF7 and U87cells, this inhibition is post-transcriptional, mediated by the 3' non translated region of CDK1 mRNA, and is associated with changes in the balance of the expression of microRNAs, which regulate potentially CDK1. We demonstrate that CDK1 is a target of miR-410 and miR-650, both induced by p16INK4a and the role of the inhibition of pRb/E2F pathway by p16INK4a in the induction of miR-410. Thus, p16INK4a regulates gene expression at different levels by modifying the functional balance of transcription factors and, consequently, the microRNAs

Submitted by Cláudia Bueno (claudiamoura18@gmail.com) on 2015-11-12T18:06:58Z No. of bitstreams: 2 Dissertação - Iane de Oliveira Pires Porto - 2014.pdf: 1352493 bytes, checksum: 3e4c1213c96035cbae32d6eeccdd14e5 (MD5) license_rdf: 23148 bytes, checksum: 9da0b6dfac957114c6a7714714b86306 (MD5) / Approved for entry into archive by Luciana Ferreira (lucgeral@gmail.com) on 2015-11-13T10:33:50Z (GMT) No. of bitstreams: 2 Dissertação - Iane de Oliveira Pires Porto - 2014.pdf: 1352493 bytes, checksum: 3e4c1213c96035cbae32d6eeccdd14e5 (MD5) license_rdf: 23148 bytes, checksum: 9da0b6dfac957114c6a7714714b86306 (MD5) / Made available in DSpace on 2015-11-13T10:33:50Z (GMT). No. of bitstreams: 2 Dissertação - Iane de Oliveira Pires Porto - 2014.pdf: 1352493 bytes, checksum: 3e4c1213c96035cbae32d6eeccdd14e5 (MD5) license_rdf: 23148 bytes, checksum: 9da0b6dfac957114c6a7714714b86306 (MD5) Previous issue date: 2014-02-19 / Conselho Nacional de Pesquisa e Desenvolvimento Científico e Tecnológico - CNPq / MicroRNAs (miRNAs) are small non-coding RNAs involved in post-transcriptional expression regulation by inducing mRNA degradation or translation inhibition. Some miRNAs are known to regulate HLA-G expression, an important immunemodulatory molecule that inhibits both Natural Killer and cytotoxic T cells through interaction with inhibitory receptors. The HLA-G is associated with maternal-fetal tolerance, tissue acceptance in transplants and the progression of tumors. The mechanisms underlying HLA-G expression control are not completely understood, however, its 3’untranslated region (3’UTR) is reported to play an important role on gene regulation influencing mRNA stability and interacting with miRNAs such as miR-148a-3p. In this study, we performed a systematic analysis of all miRNAs that are good candidates to act as HLA-G regulators. In order to determine the miRNAs with the highest potential to influence HLA-G expression, we compared the outputs of three distinct algorithms - miRanda, RNAhybrid and Pita. For this purpose, a method of miRNA inference was developed using Perl scripts to compare and filter results and a scoring system was created in order to evaluate both the binding stability of the miRNA/mRNA interaction and the miRNA specificity to its target sequence. Then, a panel of miRNAs with great potential of controlling HLA-G expression was generated. / MicroRNAs (miRNAs) são pequenos RNAs não codificantes envolvidos na regulação gênica pós-transcricional por meio da degradação da molécula de RNA mensageiro ou da inibição da tradução. Alguns miRNAs foram relatados como sendo responsáveis pela regulação da expressão do gene HLA-G, um importante imunomodulador que inibe a ação de células Natural Killer e células T citotóxicas ao interagir com receptores inibitórios. Este gene está associado à tolerância maternofetal, aceitação de tecidos após transplantes e progressão de tumores. Os mecanismos subjacentes à regulação da expressão de HLA-G não foram completamente elucidados, mas sabe-se que sua região 3’ não traduzida (3’NT) possui um papel importante na regulação gênica tanto por manter a estabilidade da molécula de mRNA quanto por interagir com miRNAs como miR-148a-3p. Neste estudo, foram inferidos miRNAs que são bons candidatos para atuarem como reguladores do gene HLA-G. Para determinar os miRNAs com o maior potencial de operarem no controle pós-transcricional dos níveis de HLA-G, comparamos os resultados de três algoritmos distintos – miRanda, RNAhybrid e Pita. Para tanto, foi desenvolvida uma estratégia de inferência de miRNAs que utiliza scripts em Perl para comparação e filtragem dos dados e um sistema de pontuação que permite avaliar tanto a estabilidade da interação miRNA/mRNA quanto a especificidade do miRNA à sua sequência alvo. Assim, um painel confiável de miRNAs com grande possibilidade de influenciar a expressão de HLA-G foi gerado considerando as regiões polimórficas e não polimórficas da região 3’NT do gene HLA-G individualmente.

Les propriétés centrales des cellules souches sont la pluripotence et la capacité d'auto-renouvellement. Les cellules souches hématopoïétiques (CSHs) sont dotées de ces caractéristiques qui leur permettent de générer toutes les cellules du compartiment hématopoïétique, tout en maintenant en parallèle leur compartiment. Nous menons des approches visant à amplifier ex vivo les CSHs en les activant par HOXB4 exogène (CSHs humaines) ou via la signalisation Notch/DLL-4 (CSHs murines). Or deux analyses transcriptomiques indépendantes de ces deux modes d'activation ont de manière étonnante convergé sur une augmentation de l'expression de deux gènes jamais identifiés auparavant comme étant impliqués dans le maintien des CSHs : Pumilio1 (Pum1) et Pumilio2 (Pum2). Pum1 et Pum2 sont des régulateurs post-transcriptionnels appartenant à la famille Pumilio-FBF (PUF) des protéines liant l'ARN. Bien qu'il ait été établi que le rôle princeps de ces protéines PUF est de soutenir la prolifération des cellules souches chez les Invertébrés, jusqu'à présent on ne sait rien du rôle de Pum1 et Pum2 dans les CSH humaines et murines.Pour toutes ces raisons, nous avons étudié le rôle et les mécanismes d'action de Pum1 et Pum2 dans les CSH murines et humaines en utilisant l'interférence ARN (ARNi). L'invalidation de Pum1 ou de Pum2 dans les CSHs murines conduit à une réduction de l'expansion et du potentiel clonogénique ex vivo, associée à une apoptose accrue et l'arrêt du cycle cellulaire en phase G0/G1. L'invalidation concomitante de Pum1 et Pum2 majore ces effets ce qui suggère un effet coopératif entre les deux protéines. L'expansion et le potentiel clonogénique des CSH invalidées pour Pum1 sont restaurés suite à l'expression forcée de Pum1 (insensible au shRNA utilisé), validant ainsi la spécificité de nos shRNAs. Par contre la surexpression de Pum1 dans les CSHs invalidées pour Pum2 ne restaure pas leurs fonctions, soulignant le rôle non redondant de chaque protéine. En outre, lorsque les CSHs invalidées pour Pum1 ou Pum2 sont inoculées à des souris irradiées létalement de suivre le potentiel hématopoïétique à long terme, seules quelques rares cellules de la moelle osseuse issues des CSH KD pour Pum1 ou Pum2 sont mises en évidence après 4 mois de reconstitution, contrairement aux CSH contrôles. Des résultats identiques ont été obtenus en invalidant Pum1 ou Pum2 dans les CSH humaines.En conclusion, nos résultats démontrent l'implication des facteurs Pumilio dans le maintien du potentiel souche, l'expansion et la survie des CSHs murines et humaines. L'identification des facteurs Pumilio et de leurs cibles comme nouveaux régulateurs des CSHs permettra d'envisager de nouveaux outils en vue de perspectives thérapeutiques. / The central properties of stem cells are the pluripotency and the capacity of self-renewal. Hematopoietic stem cells (HSCs) posses such common features that allows them to generate all the cells of the hematopoietic compartments, maintaining in the same time the HSC pool. We develop approaches focused on ex vivo HSC expansion through activation by exogenous HOXB4 (human HSCs) or Notch/Dll-4 ligand (murine HSCs). Two independent transcriptomic analyses surprisingly converged toward an increased expression of two genes never identified sofar as crucial for HSC functions: Pumilio1 (Pum1) and Pumilio2 (Pum2). Pum1 and Pum2 are posttranscriptional regulators belonging to the Pumilio-FBF (PUF) family of RNA-binding proteins. Although it was established that the primordial role of PUF proteins is to sustain mitotic proliferation of stem cells in Invertebrates, so far nothing is known about the role of Pum1 and Pum2 in human and murine HSCs.For these reasons, we have investigated the roles and mechanisms of action of Pum1 and Pum2 in murine and human HSCs through shRNA strategy. Pum1 and Pum2 knockdown (KD) in murine HSCs led to a decreased HSC expansion and clonogenic potential ex vivo, associated with an increased apoptosis and a cell cycle arrest in G0/G1 phase. KD of both Pum1 and Pum2 enhanced these effects, suggesting a cooperative effect. Expansion and clonogenic potential of KD Pum1 HSCs were rescued by enforced expression of Pum1 (insensitive to our shRNA), thus validating the specificity of our shRNA. Enforced expression of Pum1 could not rescue the functions of Pum2 KD HSCs, highlighting the non-redundant role of these proteins. Furthermore, when Pum1 or Pum2 KD HSCs were inoculated into lethally irradiated mice to follow the long-term hematopoietic potential, only rare bone marrow cells derived from Pum1 and Pum2 KD HSCs were evidenced after 4 months, contrary to control HSCs. Identical results were obtained with human Pum1 or Pum2 KD HSCs.In conclusion, our results demonstrate the involvement of Pumilio factors in stemness maintenance, expansion and survival of murine and human HSCs. Identification of Pumilio factors and their targets as new regulators of HSCs expansion will allow consider them as new tools for therapeutic perspectives.

Dans son environnement, la bactérie Escherichia coli (E. coli) fait face à d’importantes fluctuations des ressources carbonées. Une capacité d’adaptation métabolique lui permet de coloniser ou de subsister en fonction des substrats disponibles. Cette adaptation est régie par un réseau complexe de régulations de l’expression génique. Le régulateur global post-transcriptionnel CSR (Carbon Storage Regulator) régule la stabilité et/ou l’initiation de la traduction d’ARNm par l’intermédiaire de la protéine CsrA. Ce système, essentiel en présence de glucose et est également supposé être impliqué dans la régulation d’une transition métabolique glycolyse vers gluconéogenèse. Le caractère essentiel de CSR est à ce jour inexploré, tout comme son implication dans la régulation d’une adaptation métabolique. Une approche de biologie intégrative menée pour différents mutants du système CSR a permis d’avancer pour la première fois, une explication de l’essentialité de CSR lors d’une croissance exponentielle sur glucose et de caractériser son implication dans la régulation de la transition métabolique glucose-acétate. Des approches de transcriptomique et de stabilomique utilisées pour une souche sauvage au cours d’une adaptation métabolique ont mis en évidence l’importance des régulations de la stabilité des ARNm au cours de l’adaptation. En conclusion, ces travaux approfondissent grandement les connaissances concernant le système CSR et son implication dans la régulation du métabolisme d’E. coli. Ce système, indispensable à la régulation du métabolisme durant une phase de croissance sur glucose s’ajoute de façon indéniable au réseau déjà complexe de régulations du métabolisme d’E. coli / In its natural environment, Escherichia coli (E. coli) faces strong fluctuations of the nutrient availability. A complex gene regulatory network makes the bacterium able to switch between a state of growth in the presence of an appropriate carbon source and a non-growth state in its absence. Within this network, the global post-transcriptional regulator CSR (Carbon Storage Regulator) modifies mRNA stability and/or translation initiation by the CsrA protein. This system has been shown to be essential for cells to grow on glucose and is hypothesized to be involved in the regulation of metabolic transitions. However both observations remained unexplored so far. An integrative approach has been used to investigate for the first time the essentiality of CSR on glucose as well as its involvement in the regulation of the glucose-acetate transition. Molecular and phenotypic data for different mutants of the CSR system have been produced and integrated into mathematical models. Transcriptomic and Stabilomic approaches have been used eventually to characterize the importance of the control of mRNA stability during the metabolic adaptation. mRNA stability regulations appear to be of particular importance in gene expression regulation during metabolic adaptation. To conclude, this work shed a new light upon CSR’s involvement in the regulation of E. coli’s metabolism. CSR is definitely essential to regulate glycolysis and thus constitutes another regulator to be integrated into the already complex regulations network of E.coli’s metabolism